Corcept Therapeutics
CORT
#2078
Rank
C$12.53 B
Marketcap
C$118.95
Share price
1.71%
Change (1 day)
42.77%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.87 Billion

According to Corcept Therapeutics 's latest financial reports the company has C$0.87 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.97 B45.1%
2023-12-31$C$0.67 B-1.31%
2022-12-31$C$0.68 B42.18%
2021-12-31$C$0.47 B-28.23%
2020-12-31$C$0.66 B37.65%
2019-12-31$C$0.48 B29%
2018-12-31$C$0.37 B56.52%
2017-12-31$C$0.24 B331.77%
2016-12-31$C$55.6 M116.7%
2015-12-31$C$25.66 M-752.65%
2014-12-31$-C$3.94 Million-117.57%
2013-12-31$C$22.37 M-63.58%
2012-12-31$C$61.43 M73.51%
2011-12-31$C$35.4 M66.73%
2010-12-31$C$21.23 M-8.65%
2009-12-31$C$23.24 M13.08%
2008-12-31$C$20.55 M39.86%
2007-12-31$C$14.69 M98.5%
2006-12-31$C$7.4 M-76.08%
2005-12-31$C$30.96 M-43.9%
2004-12-31$C$55.18 M-235.18%
2003-12-31$-C$40.83 Million17.82%
2002-12-31$-C$34.66 Million-197.22%
2001-12-31$C$35.64 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$109.52 B 12,445.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.69 B 2,843.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$61.82 B 6,982.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$32.94 B 3,674.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 14,632.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$71.70 B 8,114.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$0.63 Billion-171.43%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$61.55 Million-107.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.36 B 858.49%๐Ÿ‡บ๐Ÿ‡ธ USA